Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2007
02/06/2007US7173030 administering oxidoreductase inhibitors such as 4-nitro-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzenesulfonamide, as wound healing agents or for the treatment of diseases or disorders, selected from diabetes, obesity, glaucoma, hyperlipidemia, hyperglycemia, hypertension, osteoporosis, and depression
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7172907 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics
02/06/2007US7172884 new strains of Sorangium cellulosum obtained by mutagenesis for the production of epothilones
02/06/2007CA2238884C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
02/06/2007CA2214320C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
02/01/2007WO2007014290A2 Fungicidal carboxamides
02/01/2007WO2007013830A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007WO2007012905A1 Colourless water-soluble organic luminophores and intermediates thereof
02/01/2007WO2006122156A3 Compounds for modulating trpv3 function
02/01/2007WO2005112919A3 Self-immolative linkers and drug conjugates
02/01/2007US20070027322 N-substituted carbamoyloxyalkyl-azolium derivatives
02/01/2007US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
02/01/2007US20070027315 Substituted 4,5,6,7-tetrahydrobenzthiazol-2-ylamine compounds
02/01/2007US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators
02/01/2007US20070027196 Activator of peroxisome proliferator-activated receptor delta
02/01/2007US20070027186 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
02/01/2007US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation
02/01/2007US20070027159 Therapeutic agents useful for treating pain
02/01/2007US20070027158 High affinity small molecule C5a receptor modulators
02/01/2007US20070027147 Biarylurea derivatives
02/01/2007US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
02/01/2007US20070027143 Novel substituted 2,3-benzodiazepine derivatives
02/01/2007US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
02/01/2007US20070027140 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics
02/01/2007US20070027138 Derivatives and analogs of galanthamine
02/01/2007US20070027115 Triazole derivatives useful in therapy
02/01/2007DE102005034406A1 Neue Salze von Rosiglitazon New salts of rosiglitazone
02/01/2007DE102005014904A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
02/01/2007CA2616377A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007CA2614288A1 Fungicidal carboxamides
01/2007
01/31/2007EP1748044A1 Thiazole compound and use thereof
01/31/2007EP1747218A2 Neuropeptide receptor modulators
01/31/2007EP1747217A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
01/31/2007EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
01/31/2007EP1747206A1 Amino-tetrazoles analogues and methods of use
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747021A2 Self-immolative linkers and drug conjugates
01/31/2007EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors
01/31/2007EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
01/31/2007EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use
01/31/2007EP1345915B1 Improved process for the preparation of water-soluble o-phosphonooxymethyl prodrugs
01/31/2007CN1906183A N-acylsulfonamide apoptosis promoters
01/31/2007CN1906178A 喹唑啉衍生物 Quinazoline derivatives
01/31/2007CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
01/31/2007CN1906173A Protein modifier production inhibitor
01/31/2007CN1906171A Substituted azole compounds, preparation and application thereof
01/31/2007CN1906169A Therapeutic agents I
01/31/2007CN1906165A Novel herbicides
01/31/2007CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
01/31/2007CN1905873A Bicyclic inhibitors of MEK and methods of use thereof
01/31/2007CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169942 Cannabinoid derivatives, methods of making, and use thereof
01/30/2007US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
01/30/2007US7169931 Cell differentiation, cell proliferation
01/30/2007US7169930 Analogs of epothilone
01/30/2007US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity
01/30/2007US7169925 Indole derivatives as interleukin-4 gene expression inhibitors
01/30/2007US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion
01/30/2007US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders
01/30/2007US7169791 Inhibitors of tyrosine kinases
01/30/2007US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
01/30/2007US7169784 Medical devices employing triazine compounds and compositions thereof
01/30/2007US7169782 Aryl substituted thiazolidinones and the use thereof
01/30/2007US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
01/30/2007US7169777 Melanocortin receptor agonists
01/30/2007US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability
01/30/2007US7169771 Thiazolyl-based compounds useful as kinase inhibitors
01/30/2007CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
01/30/2007CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
01/30/2007CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties
01/25/2007WO2007011721A1 Inhibitors of mitotic kinesin
01/25/2007WO2007011623A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007010383A1 Novel heterocyclidene acetamide derivative
01/25/2007WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof
01/25/2007WO2007009799A1 Amino acid salts of rosiglitazone
01/25/2007WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
01/25/2007WO2007009681A1 1 , 1-DIOXID0-2 , 3-DIHYDRO-l , 2-BENZISOTHIAZ0L-6-YL-1H-INDAZOL-4-YL-2 , 4-PYRIMIDINEDI AMINE DERIVATIVES
01/25/2007WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
01/25/2007WO2007009578A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
01/25/2007WO2007009524A1 2-arylbenzothiazoles and uses thereof
01/25/2007WO2007009236A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
01/25/2007WO2006131303A3 Peptide deformylase (pdf) inhibitors 4
01/25/2007WO2006126074A3 Heterocyclic derivatives
01/25/2007WO2006033005A3 Thrombopoietin receptor agonists
01/25/2007US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
01/25/2007US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
01/25/2007US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
01/25/2007US20070021477 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/25/2007US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives
01/25/2007US20070021459 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting
01/25/2007US20070021456 Aminobenzimidazole derivatives
01/25/2007US20070021452 Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy
01/25/2007US20070021447 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors
01/25/2007US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
01/25/2007US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
01/25/2007US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
01/25/2007US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections
01/25/2007US20070021407 Substituted quinolines as antitumor agents